LLY compared with RCKT: revenue, margins and what each company keeps, and the suppliers and customers both name

LLYELI Lilly & Co

Mkt capRevenueRevenue

RCKTRocket Pharmaceuticals, Inc.

Mkt capRevenueRevenue

Compare

LLYELI Lilly & Co

RCKTRocket Pharmaceuticals, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

LLY

3 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±5.1%▲+6.63%×1.29

Q2 FY26±6.2%▲+4.86%×0.79

Q1 FY26±5.3%▲+9.80%×1.85

Feb 4 '26±6.1%▲+10.33%×1.69

RCKT

0 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±29.1%▼−3.85%×0.13

May 8 '26±25.4%▼−1.09%×0.04

= impliedLLY realized, solidRCKT realized, hatchedOne scale, both sides: full bar = 30%× = |realized| ÷ impliedSource: market data

Q1 FY26

±17.9%

▲+10.60%

×0.59

Q3 FY25±24.5%▼−1.86%×0.08

LLYELI Lilly & Co

1,371.32▼−3.29%· post 1,363.77

Mkt cap$1.2TRevenue$24.4BQ3 FY26Revenue$65.2BFY25

RCKTRocket Pharmaceuticals, Inc.

2.44▼−6.70%· post 2.44

ClosedNov 5 '26

Mkt cap$286.5MRevenue—Revenue—

Compare

ClosedNov 5 '26

LLYELI Lilly & Co

RCKTRocket Pharmaceuticals, Inc.

1,371.32▼−3.29%post 1,363.77

Price

2.44▼−6.70%post 2.44

$1.2T

Mkt cap

$286.5M

Q3 FY26$24.4B

Revenue

—

FY25$65.2B

Revenue

—

LLY1,371.32▼−3.29%vsRCKT2.44▼−6.70%ClosedNov 5 '26